CAS RN: 61323-17-9
2-Bromo-1,8-naphthyridine
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: ≥98%
- Inventory rows with stock: 2
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 61323-17-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥98% |
1
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
≥98% |
1
In Stock
|
Beijing |
Inquiry |
| 1g |
≥98% |
0
Out of Stock
|
Beijing |
Inquiry |
61323-17-9 / 2-bromo-1,8-naphthyridine
Standard CAS: 61323-17-9
Multi CAS: No
Basic Information
CAS
61323-17-9
Multi CAS
No
Molecular Formula
BC8H5Rn2
Molecular Weight
209.040000
Exact Mass
207.963610
InChI
InChI=1S/C8H5BrN2/c9-7-4-3-6-2-1-5-10-8(6)11-7/h1-5H
InChIKey
BCMGOTDNNMLUBS-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
11
Aromatic heavy atom count
10
H-bond acceptors
2
Molar refractivity
47.24
TPSA
25.78
LogP / Solubility
WLOGP
2.39
MLOGP
2.11
XLogP3
2.5
Consensus LogP
2.33
Log S (ESOL)
-3.32
Class (ESOL)
Poorly soluble
Log S (Ali)
-3
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.3
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5